Privia Health Group (NASDAQ:PRVA) Now Covered by Needham & Company LLC

Equities researchers at Needham & Company LLC initiated coverage on shares of Privia Health Group (NASDAQ:PRVA - Get Free Report) in a research report issued to clients and investors on Friday, Marketbeat reports. The firm set a "buy" rating and a $25.00 price target on the stock. Needham & Company LLC's price target points to a potential upside of 21.89% from the company's previous close.

A number of other research firms have also weighed in on PRVA. KeyCorp began coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an "overweight" rating and a $23.00 price target for the company. Truist Financial upped their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a report on Friday, November 8th. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a report on Friday, November 29th. Stephens reaffirmed an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, Macquarie began coverage on Privia Health Group in a research note on Monday, December 16th. They set an "outperform" rating and a $25.00 target price on the stock. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Privia Health Group currently has a consensus rating of "Buy" and a consensus target price of $24.88.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA traded down $0.42 during mid-day trading on Friday, reaching $20.51. 969,204 shares of the company traded hands, compared to its average volume of 629,534. The company's 50 day moving average price is $20.93 and its 200-day moving average price is $19.43. The firm has a market cap of $2.46 billion, a PE ratio of 205.12, a PEG ratio of 5.45 and a beta of 0.85. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $23.24.

Institutional Trading of Privia Health Group

A number of large investors have recently made changes to their positions in the business. Canada Pension Plan Investment Board purchased a new position in Privia Health Group in the second quarter worth about $26,000. GAMMA Investing LLC boosted its holdings in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after purchasing an additional 845 shares during the period. Quarry LP increased its position in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after purchasing an additional 2,533 shares during the last quarter. KBC Group NV increased its position in shares of Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company's stock valued at $62,000 after purchasing an additional 871 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in Privia Health Group during the 3rd quarter valued at $66,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.